1.
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
by Keystone, E C
Annals of the rheumatic diseases, 2009, Vol.68 (6), p.789-796
2.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
by Smolen, Josef S
Annals of the Rheumatic Diseases, 2010, Vol.69 (6), p.964-975
3.
Global extent of chloroquine-resistant Plasmodium vivax : a systematic review and meta-analysis
by Price, Ric N, Prof
The Lancet infectious diseases, 2014, Vol.14 (10), p.982-991
4.
IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis
by Cranney, Ann
Endocrine reviews, 2002, Vol.23 (4), p.570-578
5.
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
by Ridker, Paul M, MD
The American heart journal, 2011, Vol.162 (4), p.597-605
6.
7.
Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
by Micha, Renata, RD, PhD
The American journal of cardiology, 2011, Vol.108 (9), p.1362-1370
8.
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strat...
by Dougados, Maxime
Annals of the rheumatic diseases, 2013, Vol.72 (1), p.43-50
9.
II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women
by Cranney, Ann
Endocrine reviews, 2002, Vol.23 (4), p.508-516
10.
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
by Salliot, C
Annals of the rheumatic diseases, 2009, Vol.68 (7), p.1100-1104
11.
VII. Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis
by Shea, Beverley
Endocrine reviews, 2002, Vol.23 (4), p.552-559
12.
Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
by Krieckaert, Charlotte L
Annals of the rheumatic diseases, 2012, Vol.71 (11), p.1914-1915
13.
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendation...
by Nam, J L
Annals of the rheumatic diseases, 2010, Vol.69 (6), p.976-986
14.
Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite tre...
by Keystone, Edward C
Annals of the rheumatic diseases, 2012, Vol.71 (10), p.1630-1635
15.
Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoi...
by Kavanaugh, Arthur
Annals of the rheumatic diseases, 2013, Vol.72 (1), p.64-71
16.
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis an...
by Emery, P
Annals of the rheumatic diseases, 2010, Vol.69 (9), p.1629-1635
17.
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data
by Mathurin, Philippe
Gut, 2011, Vol.60 (2), p.255-260
18.
V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women
by Wells, George
Endocrine reviews, 2002, Vol.23 (4), p.529-539
19.
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
by Westhovens, R
Annals of the rheumatic diseases, 2009, Vol.68 (12), p.1870-1877
20.
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled t...
by Song, I-H
Annals of the rheumatic diseases, 2011, Vol.70 (4), p.590-596
